PwC MoneyTree is the go-to source for Venture Capital firms and high-growth startups.
Quarterly US funding fell less than 1% in Q2'20 and declined 13% YoY amid the pandemic. Quarterly deal activity rose 3% to 1,374 transactions but declined 18% YoY.
Globally, deal activity rebounded in Q2'20 to 3,812 deals while funding decreased to $50.2b. Funding and deals are down 13% and 9% YoY, respectively. Asia saw the largest quarterly increase in deals, rising 20% in Q2'20. Quarterly deal activity in Europe rose 9% in Q2'20, compared to 3% in North America.
After three quarters of declines, 24 US-based, VC-backed companies exit in IPOs in Q2’20, up from 15 in Q1’20. On the other hand, M&A activity sees sharp decline, falling to 120 exits in Q2’20 vs. 155 in Q1’20.
Quarterly funding in Silicon Valley dipped 7% in Q2'20 to $11.7b while deal activity rose 11% to 432 deals. Three of the top 5 largest deals in the US were Silicon Valley startups raising $400m+.
The total number of US-based, VC-backed companies valued at $1b+ climbed to 209.
The PwC MoneyTree website is home to the PwC/CB Insights quarterly MoneyTree Report. It contains historical trend data (beginning in 1995), updates on the Venture Capital and high-growth startups ecosystem and relevant insights from PwC’s emerging company services and venture capital tax, audit and advisory professionals. The PwC/CB Insights MoneyTree Report is the definitive source of information on venture capital investments in emerging companies. This study is a staple of the financial community, entrepreneurs, government policymakers and the business press worldwide.
Partner, US Pharmaceuticals and Life Sciences, PwC US
US Asset and Wealth Management Leader, PwC US
Assurance Director, PwC US